Evaluation of outcomes for psychosis and epilepsy treatment delivered by primary health care workers in Nepal: a cohort study

Table 6 Functional impairment combined for epilepsy and psychosis

	Program		Control		ANCOVA		Full cohort (n = 156) T
	Mean	(SD)	Mean	(SD)	Effect size F, partial eta²	P-val*	Mean	(SD)	Effect size Z, r	P-val**
WHODAS					1.78, 0.01	0.18			7.83, 0.63	< 0.0001
Baseline	39.9	(22.8)	31.2	(23.8)			37.8	(23.2)
end point	15.4	(21.8)	19.4	(28.7)			16.3	(23.6)
Δ score	− 24.5	(27.8)	− 11.8	(33.5)			− 21.5	(29.6)
BAS					0.01, < 0.01	0.92			10.56, 0.85	< 0.0001
Baseline	74.4	(8.1)	72.2	(9.2)			73.9	(8.4)
end point	60.4	(6.9)	59.6	(8.1)			60.2	(7.2)
Δ score	− 14.0	(8.8)	− 12.6	(10.0)			− 13.7	(9.1)

WHODAS World Health Organization Disability Assessment Schedule 2.0 Short Version, BAS burden assessment schedule
* P-value taken from ANCOVA (analysis of covariance) for each scale comparing program vs. control scores at end point, adjusted for baseline score
** P-value from Wilcoxon Signed-Rank Test comparing baseline to end point scores (full cohort)

ISSN: 1752-4458